29.7 percent of those aged 60 years or older reported primary prevention use in 2021, with 5.2 percent using without medical advice
Childhood Risk Factors Directly Tied to Adult Cardiovascular Disease
Largest direct effect seen for childhood BMI and low-density lipoprotein cholesterol
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
Approval allows for use in nonambulatory individuals ≥4 years with a confirmed gene mutation
Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN
High versus low VPA linked to lower risk of MCI, probable dementia, MCI/probable dementia in multivariate model
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
Combining NT-proBNP and IL-1 RL1 tests performed well, enabling additional identification of asymptomatic babies